---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-003160"
form_type: "8-K"
ticker: "PROF"
cik: "0001628808"
company_name: "Profound Medical Corp."
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T21:49:00.185444+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Profound Medical Reports Strong Q1 2026 Results with 104% Revenue Growth and Humana Coverage

## Summary
- Revenue grew 104% year-over-year to $5.3M, with $2.5M recurring and $2.9M capital equipment.
- Net loss improved 34% to $7.0M ($0.19 per share) from $10.7M in Q1 2025.
- Humana became first national U.S. payor to cover the TULSA Procedure, adding ~8.5M covered lives.
- CAPTAIN trial met primary safety endpoint; TULSA INDEX20 average procedures per quarter rose to 11.3.
- Full-year 2026 revenue guidance set at ~$25M, representing 56% growth over prior year.

## SEC filing metadata
- accession: 0001171843-26-003160
- form_type: 8-K
- ticker: PROF
- cik: 0001628808
- company_name: Profound Medical Corp.
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628808/000117184326003160/0001171843-26-003160-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628808/000117184326003160/f8k_050726.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-003160
- JSON: https://secwatch.observer/filing/0001171843-26-003160.json
- Plain text: https://secwatch.observer/filing/0001171843-26-003160.txt

## Source-grounded claims
- claim_id: c1e843fee7e9fcad965c140ab1437c6bc7b3c8ab
  claim: Profound Medical Corp. reported the first quarter ended March 31, 2026 results: revenue $5.3 million, net income $7.0 million, EPS $0.19 per common share. Guidance initiated.
  evidence_excerpt: For the quarter ended March 31, 2026, Profound recorded revenue of approximately $5.3 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1628808/000117184326003160/0001171843-26-003160-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.